 |
 |

Response to Levodopa Treatment in Dopa-Responsive Dystonia
John G. Nutt, MD;
Torbjoern G. Nygaard, MD
Arch Neurol. 2001;58:905-910.
Background Dopa-responsive dystonia (DRD) is similar to Parkinson disease in that
both disorders have impaired dopamine synthesis and respond to levodopa treatment.
Dopa-responsive dystonia differs in that dopamine storage is intact in contrast
to Parkinson disease in which it is markedly reduced.
Objective To examine the short- and long-duration responses to levodopa dosing
in subjects with DRD.
Methods The response to brief infusions of levodopa was examined in 4 subjects
with DRD and the effects of withdrawal of levodopa for 3 to 7 days studied
in the 3 subjects receiving long-term levodopa therapy. Motor function was
measured with tapping speed, Unified Parkinson's Disease Rating Scale motor
score, and global dystonia score.
Results The short-duration response to levodopa dosing seems to develop more
slowly and persists longer in subjects with DRD than in subjects with Parkinson
disease. Withdrawal of levodopa leads to a gradual decline in tapping speed
and reemergence of dystonia over several days, similar to the rate of decay
of motor function in Parkinson disease. The short- and long-duration responses
were not clearly differentiated in DRD.
Conclusions This pilot study suggests that retained dopamine storage in DRD may
prolong the short-duration response and blur the distinction of the short-
and long-duration responses. The decline in motor function in DRD on withdrawal
of long-term levodopa therapy resembles that in Parkinson disease, suggesting
that a long-duration response, if it exists in DRD, is unrelated to dopamine
storage.
From the Departments of Neurology and Physiology and Pharmacology,
Oregon Health Sciences University, Portland (Dr Nutt); Department of Neurology,
East Orange Veterans Affairs Medical Center, East Orange, NJ (Dr Nygaard);
and the Department of Neurosciences, University of Medicine and DentistryNew
Jersey Medical School, Newark, NJ (Dr Nygaard).
Corresponding author: John G. Nutt, MD, Department of Neurology,
OP 32, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd, Portland,
OR 97201-3098.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(6):1028-1029.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Intracortical inhibition of the motor cortex in Segawa disease (DYT5)
Hanajima et al.
Neurology 2007;68:1039-1044.
ABSTRACT
| FULL TEXT
Broadening the Phenotype of Childhood-Onset Dopa-Responsive Dystonia.
Chaila et al.
Arch Neurol 2006;63:1185-1188.
ABSTRACT
| FULL TEXT
Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
Wider et al.
Arch Neurol 2006;63:951-955.
ABSTRACT
| FULL TEXT
Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model
de la Fuente-Fernandez et al.
Brain 2004;127:888-899.
ABSTRACT
| FULL TEXT
|